肠道菌群与慢性病发生发展的研究进展(7)
[33] An J， Ha EM. Combination therapy of lactobacillus plantarum supernatant and 5-fluouracil increases chemosensitivity in colorectal cancer cells[J]. J Microbiol Biotechnol， 2016， 26(8)： 1490-1503.
[34] Sun MF， Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s disease[J]. Ageing Res Rev， 2018， 45： 53-61.
[35] Sampson TR， Debelius JW， Thron T， et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease[J]. Cell， 2016， 167(6)： 1469-1480.
[36] Tamtaji OR， Taghizadeh M， Daneshvar Kakhaki R， et al. Clinical and metabolic response to probiotic administration in people with Parkinson’s disease： a randomized， double-blind，placebo-controlled trial[J/OL]. Clin Nutr， 2018. doi： 10.1016/ j.clnu.2018.05.018.
[37] Zhao Y， Jaber V， Lukiw WJ. Secretory products of the human GI tract microbiome and their potential impact on Alzheimer’s disease (AD)： detection of lipopolysaccharide (LPS) in AD hippocampus[J/OL]. Front Cell Infect Microbiol， 2017， 7： 318. doi： 10.3389/fcimb.2017.00318., 百拇医药(张晓辉 高仁元 秦环龙)
[34] Sun MF， Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s disease[J]. Ageing Res Rev， 2018， 45： 53-61.
[35] Sampson TR， Debelius JW， Thron T， et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease[J]. Cell， 2016， 167(6)： 1469-1480.
[36] Tamtaji OR， Taghizadeh M， Daneshvar Kakhaki R， et al. Clinical and metabolic response to probiotic administration in people with Parkinson’s disease： a randomized， double-blind，placebo-controlled trial[J/OL]. Clin Nutr， 2018. doi： 10.1016/ j.clnu.2018.05.018.
[37] Zhao Y， Jaber V， Lukiw WJ. Secretory products of the human GI tract microbiome and their potential impact on Alzheimer’s disease (AD)： detection of lipopolysaccharide (LPS) in AD hippocampus[J/OL]. Front Cell Infect Microbiol， 2017， 7： 318. doi： 10.3389/fcimb.2017.00318., 百拇医药(张晓辉 高仁元 秦环龙)